The Export Control Legislation Amendment (Certification of Narcotic Exports) Bill 2020, which passed the Senate on June 17, will allow the Commonwealth Department of Agriculture, Water and the Environment to…

A CBD product might soon be available and subsidised on the Pharmaceutical Benefits Scheme   Families of children with severe drug-resistant epilepsy might soon be able to access a subsidised…

NZ recreational cannabis bill released - prioritises social good over profits New Zealanders will go to the polls on September 19 to vote for their federal government as well as…

Australian government proposes CBD be made available for retail sale Today the Therapeutic Goods Administration released the Department of Health-initiated proposal to make low-dose CBD oil available for sale in…

Australian Senate Committee tables recommendations from inquiry into barriers to medical cannabis The Community Affairs and References Committee tabled their report today (25/3/20) on the inquiry into barriers to medical…

What does a global recession mean for the cannabis industry? COVID-19 is wreaking havoc on the global economy. And there are genuine concerns about a prolonged economic downturn, unlike any…

Medical cannabis quality crack-down   The Therapeutic Goods Administration (TGA) has announced it will be ramping up the number of quality audits it conducts on imported medical cannabis products. This…

We attended the ODC’s consultation session on proposed medical cannabis license changes so you didn’t have to The Office of Drug Control (ODC) held consultation sessions in three capital cities…

[gdlr_core_button button-text="See the Webinar" button-link="https://attendee.gotowebinar.com/recording/5834975572267909131" button-link-target="_blank" margin-right="20px" ]

The TGA is re-examining the clinical evidence for medical cannabis - including over-the-counter CBD This is the third article in our series about the Department of Health's submission to the…